BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31505164)

  • 1. Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).
    Scobie MR; Houke HR; Rice CD
    Chem Biol Interact; 2019 Oct; 312():108816. PubMed ID: 31505164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) is a potent modulator of LPS-stimulated macrophage functions.
    Babcock AS; Anderson AL; Rice CD
    Toxicol Appl Pharmacol; 2013 Jan; 266(1):157-66. PubMed ID: 23107598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
    Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
    Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling.
    Zhang Y; Du Z; Zhuang Z; Wang Y; Wang F; Liu S; Wang H; Feng H; Li H; Wang L; Zhang X; Hao A
    J Neurooncol; 2015 Nov; 125(2):265-75. PubMed ID: 26386687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indirubin derivative 6-bromoindirubin-3'-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference.
    Czapka A; König S; Pergola C; Grune C; Vougogiannopoulou K; Skaltsounis AL; Fischer D; Werz O
    Biochem Pharmacol; 2020 Oct; 180():114170. PubMed ID: 32710971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of indirubin derivatives on influenza A virus-infected human pulmonary microvascular endothelial cells.
    Kwok HH; Poon PY; Fok SP; Ying-Kit Yue P; Mak NK; Chan MC; Peiris JS; Wong RN
    Sci Rep; 2016 Jan; 6():18941. PubMed ID: 26732368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An indirubin derivative, E804, exhibits potent angiosuppressive activity.
    Chan YK; Kwok HH; Chan LS; Leung KS; Shi J; Mak NK; Wong RN; Yue PY
    Biochem Pharmacol; 2012 Mar; 83(5):598-607. PubMed ID: 22178720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
    Nam S; Buettner R; Turkson J; Kim D; Cheng JQ; Muehlbeyer S; Hippe F; Vatter S; Merz KH; Eisenbrand G; Jove R
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5998-6003. PubMed ID: 15837920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirubin Derivative 7-Bromoindirubin-3-Oxime (7Bio) Attenuates Aβ Oligomer-Induced Cognitive Impairments in Mice.
    Chen L; Huang C; Shentu J; Wang M; Yan S; Zhou F; Zhang Z; Wang C; Han Y; Wang Q; Cui W
    Front Mol Neurosci; 2017; 10():393. PubMed ID: 29234273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins.
    Knockaert M; Blondel M; Bach S; Leost M; Elbi C; Hager GL; Nagy SR; Han D; Denison M; Ffrench M; Ryan XP; Magiatis P; Polychronopoulos P; Greengard P; Skaltsounis L; Meijer L
    Oncogene; 2004 May; 23(25):4400-12. PubMed ID: 15077192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats.
    Heshmati N; Cheng X; Eisenbrand G; Fricker G
    J Pharm Sci; 2013 Oct; 102(10):3792-9. PubMed ID: 23934779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3'-oxime (7BIO).
    Broecker-Preuss M; Becher-Boveleth N; Gall S; Rehmann K; Schenke S; Mann K
    Cancer Cell Int; 2015; 15():97. PubMed ID: 26464561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterization and in vitro permeation of an indirubin derivative.
    Heshmati N; Wagner B; Cheng X; Scholz T; Kansy M; Eisenbrand G; Fricker G
    Eur J Pharm Sci; 2013 Nov; 50(3-4):467-75. PubMed ID: 23994641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of discrete apoptotic pathways by bromo-substituted indirubin derivatives in invasive breast cancer cells.
    Nicolaou KA; Liapis V; Evdokiou A; Constantinou C; Magiatis P; Skaltsounis AL; Koumas L; Costeas PA; Constantinou AI
    Biochem Biophys Res Commun; 2012 Aug; 425(1):76-82. PubMed ID: 22820195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirubin 3'-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent.
    Ichimaru Y; Saito H; Uchiyama T; Metori K; Tabata K; Suzuki T; Miyairi S
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1403-6. PubMed ID: 25765906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway.
    Chen L; Wang J; Wu J; Zheng Q; Hu J
    Drug Des Devel Ther; 2018; 12():3335-3342. PubMed ID: 30323565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
    Schwaiberger AV; Heiss EH; Cabaravdic M; Oberan T; Zaujec J; Schachner D; Uhrin P; Atanasov AG; Breuss JM; Binder BR; Dirsch VM
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2475-81. PubMed ID: 20847306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.
    Michaud-Levesque J; Bousquet-Gagnon N; Béliveau R
    Exp Cell Res; 2012 May; 318(8):925-35. PubMed ID: 22394507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins.
    Myrianthopoulos V; Magiatis P; Ferandin Y; Skaltsounis AL; Meijer L; Mikros E
    J Med Chem; 2007 Aug; 50(17):4027-37. PubMed ID: 17665890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.